Forging the future of cell therapy: Bayer and ҹѰ’s unique journey

In this episode of The Top Line, Fierce Biotech’s Chris Hayden sat down with Dr. Juergen Eckhardt of Bayer and Dr. Seth Ettenberg of ҹѰ Therapeutics to discuss an innovative partnership that’s reshaping how big pharma teams up with biotech startups.

Related News

Podcasts

Eye on the Cure Podcast

June 5, 2025
Podcasts

Cell & Gene The Podcast: Inside ҹѰ Therapeutics’ Parkinson’s Disease Trial

April 25, 2024
Podcasts

Headlines of the Future Podcast: The Future of Cell and Gene Therapies

November 22, 2023
Podcasts

Eye on the Cure Podcast

June 5, 2025
Podcasts

Cell & Gene The Podcast: Inside ҹѰ Therapeutics’ Parkinson’s Disease Trial

April 25, 2024
Podcasts

Headlines of the Future Podcast: The Future of Cell and Gene Therapies

November 22, 2023